Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

被引:4
|
作者
Ng, Hoi Man [1 ]
Lei, Chon Lok [2 ]
Fu, Siyi [2 ]
Li, Enqin [2 ]
Leong, Sek In [1 ]
Nip, Chu Iong [1 ]
Choi, Nga Man [1 ]
Lai, Kai Seng [1 ]
Tang, Xi Jun [3 ]
Lei, Chon Leng [1 ]
Xu, Ren-He [2 ]
机构
[1] Kiang Wu Hosp, Lab Dept, Macau, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Macau, Peoples R China
[3] Zhuhai Hosp Combined Tradit Chinese & Western Med, Lab Dept, Zhuhai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
SARS-CoV-2; inactivated vaccine; mRNA vaccine; heterologous vaccinations; antibodies; spike proteins; nucleocapsid proteins; Macao;
D O I
10.3389/fimmu.2023.1131985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mRNA vaccines (RVs) can reduce the severity and mortality of severe acute respiratory syndrome coronavirus (SARS-CoV-2). However, almost only the inactivated vaccines (IVs) but no RVs had been used in mainland China until most recently, and the relaxing of its anti-pandemic strategies in December 2022 increased concerns about new outbreaks. In comparison, many of the citizens in Macao Special Administrative Region of China received three doses of IV (3IV) or RV (3RV), or 2 doses of IV plus one booster of RV (2IV+1RV). By the end of 2022, we recruited 147 participants with various vaccinations in Macao and detected antibodies (Abs) against the spike (S) protein and nucleocapsid (N) protein of the virus as well as neutralizing antibodies (NAb) in their serum. We observed that the level of anti-S Ab or NAb was similarly high with both 3RV and 2IV+1RV but lower with 3IV. In contrast, the level of anti-N Ab was the highest with 3IV like that in convalescents, intermediate with 2IV+1RV, and the lowest with 3RV. Whereas no significant differences in the basal levels of cytokines related to T-cell activation were observed among the various vaccination groups before and after the boosters. No vaccinees reported severe adverse events. Since Macao took one of the most stringent non-pharmaceutical interventions in the world, this study possesses much higher confidence in the vaccination results than many other studies from highly infected regions. Our findings suggest that the heterologous vaccination 2IV+1RV outperforms the homologous vaccinations 3IV and 3RV as it induces not only anti-S Ab (to the level as with 3RV) but also anti-N antibodies (via the IV). It combines the advantages of both RV (to block the viral entry) and IV (to also intervene the subsequent pathological processes such as intracellular viral replication and interference with the signal transduction and hence the biological functions of host cells).
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao (Vol 14, 1131985, 2023)
    Ng, Hoi Man
    Lei, Chon Lok
    Fu, Siyi
    Li, Enqin
    Leong, Sek In
    Nip, Chu Iong
    Choi, Nga Man
    Lai, Kai Seng
    Tang, Xi Jun
    Lei, Chon Leng
    Xu, Ren-He
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
    Lau, Chin Shern
    Oh, May Lin Helen
    Phua, Soon Kieng
    Liang, Ya Li
    Li, Yanfeng
    Huo, Jianxin
    Huang, Yuhan
    Zhang, Biyan
    Xu, Shengli
    Aw, Tar Choon
    ANTIBODIES, 2022, 11 (02)
  • [3] LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins
    Haljasmagi, Liis
    Remm, Anu
    Rumm, Anna Pauliina
    Krassohhina, Ekaterina
    Sein, Hanna
    Tamm, Anu
    Kisand, Kai
    Peterson, Part
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (08) : 1234 - 1236
  • [4] Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
    Kurt, Feyza Guel Oezbay
    Lepper, Alisa
    Gerhards, Catharina
    Roemer, Mathis
    Lasser, Samantha
    Arkhypov, Ihor
    Bitsch, Rebekka
    Bugert, Peter
    Altevogt, Peter
    Gouttefangeas, Cecile
    Neumaier, Michael
    Utikal, Jochen
    Umansky, Viktor
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/ Omicron variants following an inactivated whole-virus vaccine
    Lu, Changrui
    Zhang, Yuntao
    Liu, Xiaohu
    Hou, Fujun
    Cai, Rujie
    Yu, Zhibin
    Liu, Fei
    Yang, Guohuan
    Ding, Jun
    Xu, Jiang
    Hua, Xianwu
    Cheng, Xinhua
    Pan, Xinping
    Liu, Lianxiao
    Lin, Kang
    Wang, Zejun
    Li, Xinguo
    Lu, Jia
    Zhang, Qiu
    Li, Yuwei
    Hu, Chunxia
    Fan, Huifen
    Liu, Xiaoke
    Wang, Hui
    Jia, Rui
    Xu, Fangjingwei
    Wang, Xuewei
    Huang, Hongwei
    Zhao, Ronghua
    Li, Jing
    Cheng, Hang
    Jia, William
    Yang, Xiaoming
    ANTIVIRAL RESEARCH, 2023, 212
  • [6] Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
    Meng, Ziyan
    Ma, Danjing
    Duan, Suqin
    Zhang, Jingjing
    Yue, Rong
    Li, Xinghang
    Gao, Yang
    Li, Xueqi
    Zeng, Fengyuan
    Xu, Xiangxiong
    Jiang, Guorun
    Liao, Yun
    Fan, Shengtao
    Niu, Zhenye
    Li, Dandan
    Yu, Li
    Zhao, Heng
    Xu, Xingli
    Wang, Lichun
    Zhang, Ying
    Liu, Longding
    Li, Qihan
    VACCINES, 2022, 10 (06)
  • [7] Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine
    Debes, Amanda K.
    Xiao, Shaoming
    Egbert, Emily R.
    Caturegli, Patrizio
    Gadala, Avinash
    Colantuoni, Elizabeth
    Sitaras, Ioannis
    Pekosz, Andrew
    Milstone, Aaron M.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [8] Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants
    Zou, Lirong
    Zhang, Huan
    Zheng, Zhonghua
    Jiang, Yushan
    Huang, Yushi
    Lin, Shujian
    Yu, Jianxiang
    Deng, Xiaoling
    He, Jianfeng
    Shen, Chenguang
    Li, Baisheng
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (12) : 6065 - 6072
  • [9] Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
    Konstantinidis, Theocharis G.
    Zisaki, Stavroula
    Mitroulis, Ioannis
    Konstantinidou, Eleni
    Kontekaki, Eftychia G.
    Romanidou, Gioulia
    Karvelas, Alexandros
    Nanousi, Ioanna
    Lazidis, Leonidas
    Cassimos, Dimitrios
    Tsigalou, Christina
    Martinis, Georges
    Panopoulou, Maria
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [10] Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
    Wang, Xun
    Zhao, Xiaoyu
    Song, Jieyu
    Wu, Jing
    Zhu, Yuqi
    Li, Minghui
    Cui, Yuchen
    Chen, Yanjia
    Yang, Lulu
    Liu, Jun
    Zhu, Huanzhang
    Jiang, Shibo
    Wang, Pengfei
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 477 - 481